|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
N/A
|
National Institutes of Health
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
4R01CA173481-04
|
$389,781
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-02
|
$366,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of exRNA in Health Disparity of Prostate Cancer
|
5R21CA194750-02
|
$162,426
|
ABD ELMAGEED, ZAKARIA
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
5R01CA123484-09
|
$284,744
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Prostate Cancer Recurrence: models and mechanisms
|
5R01CA167966-05
|
$362,601
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
4P50CA094056-16
|
$1,286,033
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
2U54CA163069-06
|
$1,401,481
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
|
1F99CA212455-01
|
$30,550
|
AFFRONTI, HAYLEY
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-02S1
|
$400,000
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-03
|
$737,200
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting galectin-3 for prostate cancer therapy
|
1R43CA203420-01
|
$224,881
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
Targeting galectin-3 for prostate cancer therapy
|
3R43CA203420-01S1
|
$40,000
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
SELECT and Prostate Cancer Prevention Trial (PCPT)
|
ZIA CP010221-10405
|
$266,030
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S1
|
$244,135
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S2
|
$124,997
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S3
|
$109,572
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
3P30CA138313-08S4
|
$104,650
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
5P30CA138313-08
|
$2,093,000
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-03
|
$1,295,865
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Novel Molecular Therapies of Prostate Cancer
|
2P01CA140043-07A1
|
$1,272,322
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Control of Apoptosis in Cancer by Survivin
|
5R01CA078810-19
|
$380,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-03
|
$316,934
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-03
|
$497,800
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Maryland Prostate Cancer Case-Control Study
|
ZIA BC 010499
|
$427,212
|
Ambs, Stefan
|
CCR (NCI)
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$244,121
|
Ambs, Stefan
|
CCR (NCI)
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIA BC 010886
|
$61,030
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
The development of radiolabeled probes for imaging and therapy which target the chemokine CXCR4
|
1F32CA203473-01
|
$56,118
|
AMOR-COARASA, ALEJANDRO
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Clinical bacterial isolate engineered as an immunotherapy for prostate cancer
|
1F30CA203472-01
|
$48,576
|
ANKER, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-03
|
$541,578
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Characterization of Epigenetic Targets in Prostate Cancer
|
5R00CA187664-04
|
$249,000
|
ASANGANI, IRFAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
3P30CA082103-18S1
|
$121,856
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S2
|
$155,534
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S3
|
$60,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S4
|
$80,100
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S5
|
$200,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S6
|
$152,100
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S7
|
$200,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology
|
5R01CA200064-02
|
$621,871
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Functional Investigation of the Mitochondrial Pyruvate Carrier in Prostate Cancer
|
5F30CA196108-02
|
$41,438
|
BADER, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
1R35CA197684-01
|
$848,325
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
4P01CA163227-04
|
$2,045,071
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|